Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer
NCT01197209
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Suspended due to change in development plans and investigator
Conditions
Prostate Cancer
Interventions
BIOLOGICAL:
Ad-REIC/Dkk-3
Sponsor
Momotaro-Gene Inc.
Collaborators
[object Object]